The observation that cardiovascular marker clinical use could aid cognitive risk assessment is encouraging, but more research is needed to establish whether the exemplars of GDF15 or combinations of biomarkers could potentially aid in identifying individuals at particular risk for cognitive decline in whom drug treatments, intensive cardiovascular risk factor modification, and early cognitive interventions may be helpful. Here, GDF15 is linked to Mental deterioration.